ABSTRACT NUMBER: ESOC2026A519 BRIDGE-TNK SUBGROUP ANALYSIS: TNK PLUS ENDOVASCULAR THROMBECTOMY FOR AIS WITH TANDEM LESIONS
Zhenyu Kong, Zhongming Qiu, Bo Yang, Thanh N Nguyen, Jeffrey Saver, Tao Cui, Xiuli Wang, Hongfei Sang, Qingwu Yang · 2026
Read ABSTRACT NUMBER: ESOC2026A519 BRIDGE-TNK SUBGROUP ANALYSIS: TNK PLUS ENDOVASCULAR THROMBECTOMY FOR AIS WITH TANDEM LESIONS by Zhenyu Kong, Zhongming Qiu, Bo Yang, Thanh N Nguyen, Jeffrey Saver, Tao Cui, Xiuli Wang, Hongfei Sang, Qingwu Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146270.txt.
Description
Zhenyu Kong and co-authors present a 2026 conference study on a fast clot drug given before clot removal when two blockages strike at once. The drug, tenecteplase, is proven as a bridge to the procedure in plain cases. Paired blockages often need extra steps that may clash with the drug.
The work reuses the BRIDGE-TNK trial, with five hundred fifty patients, sixty-three of them with paired blockages. Without the pairing, the drug raised independence at ninety days by a clear margin. With the pairing, the drug group did worse on independence and had higher death rates. Bleeding gaps stayed unclear in the small paired group. The authors warn the pairing may flip the drug's value.
Catalog record
| CREATOR | Zhenyu Kong, Zhongming Qiu, Bo Yang, Thanh N Nguyen, Jeffrey Saver, Tao Cui, Xiuli Wang, Hongfei Sang, Qingwu Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |